弥漫性甲状腺肿

mí màn xìnɡ jiǎ zhuànɡ xiàn zhǒnɡ
  • diffuse goiter
弥漫性甲状腺肿弥漫性甲状腺肿
  1. 目的:观察中药泻火养阴散治疗初发毒性弥漫性甲状腺肿(格雷夫斯病)的治疗效果。

    Objective : To observe the therapeutic effect of Xiehuo Yangyin powder ( XHYY ) in treating the initial stage of toxic and diffuse goiter ( Graves disease ) .

  2. 毒性弥漫性甲状腺肿患者血清IL-1、IL-2、IL-6水平变化的分析

    The Changes of Serum IL-1 、 IL-2 and IL-6 Levels in Graves Disease Patients

  3. 目的观察中成药抑亢丸辅助治疗青春期弥漫性甲状腺肿伴甲亢(Graves病)疗效。

    Objective To observe curative effect of Chinese patent drug " Yikang Wan " on treating Graves disease of adolescence .

  4. 16例甲状腺功能正常的弥漫性甲状腺肿患儿TSH值均在正常范围上限;

    In 16 euthyroids were all in the normal range , but concentrated on the upper limit of normal ;

  5. 本文报道一例毒性弥漫性甲状腺肿患者合并有胰岛素自身免疫综合症(IAS)。

    A case of insulin autoimmune syndrome ( IAS ) is reported and the related literature reviewed .

  6. 目的:探讨弥漫性甲状腺肿伴甲亢(Graves病)患者的氧化/抗氧化平衡紊乱以及抗甲状腺药物内基硫氧嘧啶(PTU)治疗的影响。

    OBJECTIVE : To study the oxidant / antioxidant status of Graves'disease and effect ofpropylthiouracil ( PTU ) on it .

  7. 目的:探讨抗甲状腺药物(ATD)对毒性弥漫性甲状腺肿即Graves病(GD)患者治疗前后心率变异性(HRV)的影响。

    To study the effect of anti-thyroid drug ( ATD ) on heart rate variation ( HRV ) in patients with Graves disease ( GD ) .

  8. 方法:弥漫性甲状腺肿伴甲亢患者108例,分别用甲状腺功能仪及SPECT的感兴趣区法(ROI)测定甲状腺摄131I率,比较得出两种剂量摄131I率的关系。

    METHODS : Thyroid function instrument and the region of interest ( ROI ) method on SPECT were performed in 108 patients with hyperthyroidism to measure thyroid uptake ratio ( TUR ) of tracer and therapeutic 131 I dose .

  9. 免疫抑制剂局部注射治疗弥漫性甲状腺肿伴甲亢的疗效观察

    Topical intrathyroid injection of immunosuppressive agents in treatment of Graves ' disease

  10. 毒性弥漫性甲状腺肿合并周期性麻痹临床分析

    Clinical analysis of graves ' disease accompanied with periodic paralysis

  11. 毒性弥漫性甲状腺肿1例(1.3%)。

    Diffuse toxic goiter 1 case ( 1.3 % ) .

  12. 弥漫性甲状腺肿在一定程度上是结节状。

    This diffusely enlarged thyroid gland is somewhat nodular .

  13. 弥漫性甲状腺肿伴甲亢症患者的生存质量及相关心理社会因素

    Quality of life and affective psychosocial factors of patients with Graves ' disease

  14. 毒性弥漫性甲状腺肿病人的健康教育

    Health education of patients with Graves disease

  15. 弥漫性甲状腺肿伴甲状腺功能亢进症患者111例心理状态测试

    Test of the psychological condition of 111 patients with diffuse toxic goiter accompanied by hyperthyroidism

  16. 毒性弥漫性甲状腺肿~(131)I治疗病人的护理

    Nursing care of patients with Graves disease underwent Iodine ( ~ ( 131 ) I ) therapy

  17. 本文对单纯性甲状腺肿、毒性弥漫性甲状腺肿、亚急性甲状腺炎和桥本甲状腺炎引起的112例弥漫性甲状腺肿的B超显像、临床表现和实验室检查结果进行了综合分析。

    112 cases with diffuse thyromegaly resulted from simple goiter , subacute thyroiditis . hashimoto thyroiditis and toxic diffuse goiter were examined with B-mode ultrasonography , The results were compared with clinical presentation and laboratory investigation .

  18. 目的:探讨弥漫性毒性甲状腺肿(Gravesdisease,GD)对人体血清白细胞介素-2(IL-2)、白细胞介素-8(IL-8)、肿瘤坏死因子(TNF)水平的影响。

    Objective : To evaluate the influence of Graves disease on the serum levels of interleukin-2 ( IL-2 ), interleukin-8 ( IL-8 ) and TNF .

  19. 利用放射性核素131I治疗弥漫性毒性甲状腺肿已经成为临床的主要方法之一。

    The use of radionuclide131I in treatment of diffuse toxic goiter has become one of the main clinical methods .

  20. 弥漫性毒性甲状腺肿的二维及彩色多普勒超声特征

    The Characteristics of Two - dimensional and Color Doppler Ultrasonography in Graves ' Disease

  21. 结果碘过量组小鼠出现了弥漫胶质性甲状腺肿;

    Results Iodine-excess groups show diffused colloid goiter ;